熱門資訊> 正文
Reviva Pharmaceuticals宣布拟议公开募股
2025-09-19 04:18
- Reviva Pharmaceuticals Holdings (NASDAQ:RVPH) on Thursday said it intends to offer shares of its common stock and warrants to purchase shares of common stock in a public offering.
- All of the securities to be sold in the offering are to be offered by Reviva.
- The company currently intends to use the net proceeds from the offering to fund research and development activities and for working capital and other general corporate purposes.
- RVPH -21.31% after hours to $0.33.
- Source: Press Release
More on Reviva Pharmaceuticals
- Reviva Pharmaceuticals holdings announces pricing of $10M public offering
- Seeking Alpha’s Quant Rating on Reviva Pharmaceuticals
- Historical earnings data for Reviva Pharmaceuticals
- Financial information for Reviva Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
